Physician profile
Jay Carter Johnston
NPI 1427078468
$1,782.39
in general payments reported to CMS, 2019-2025
14 companies · $548 in 2025
The $548 reported for 2025 was more than what 79% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10.84 · 2020: $13.33 · 2021: $146 · 2022: $229 · 2023: $361 · 2024: $475 · 2025: $548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,359 · Entertainment: $24.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,359.13 |
| Entertainment | $24.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $501.33 | 2021-2025 | Acuvue |
| Abbvie INC. | $367.64 | 2022-2025 | |
| Rxsight INC | $275.08 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Alcon Vision LLC | $272.71 | 2020-2025 | Simbrinza, Clareon, Argos |
| Abb Con-Cise Optical Group LLC | $62.22 | 2023 | Contact Lens, Spectacle Lenses |
| Dompe US, INC. | $56.81 | 2024-2025 | Oxervate |
| Oyster Point Pharma, INC. | $47.47 | 2023-2025 | Tyrvaya, Ryzumvi |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $42.47 | 2021 | |
| Bausch & Lomb Americas INC. | $37.38 | 2023-2025 | Vyzulta, Zylet, Miebo |
| Aerie Pharmaceuticals, INC. | $29.84 | 2019-2021 | |
| Harrow Eye, LLC | $25.51 | 2025 | Vevye |
| Optos, INC. | $24.52 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Tarsus Pharmaceuticals, INC. | $20.23 | 2024 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $19.18 | 2025 | Tecnis Iol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.